FDA Town Hall

11:00 AM–12:15 PM Jun 4, 2019 (US - Eastern)

113ABC, Level 100


The session will be organized as an interactive, moderated roundtable discussion of FDA center priorities followed by a question-and-answer session with the audience. Topics that will be addressed during the roundtable will include the FDA’s perspectives on critical topics such as PDUFA VI implementation; efforts to advance innovation and expedite patient access to novel therapies for serious and life-threatening conditions; novel approaches to integrating new scientific tools into FDA regulatory practices at all levels; and FDA resources and scientific infrastructure.

Session ID: 538286